Myocardial Protection of L-carnitine in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

李亚萍,郭丽君,张福春,李昭屏,高炜
DOI: https://doi.org/10.3969/j.issn.1004-8812.2006.04.001
2006-01-01
Abstract:Objective To evaluate the myocardial protection effects of L-carnitine in patients with acute myocardial infarction (AMI) undergoing primary percutaneous coronary intervention (PCI). Methods Forty-two consecutive patients with ST elevation MI undergoing primary PCI within 12 hours from symptom onset were randomized to two groups, the L-CN treated group (n=22) and control group (n=20). The incidence of reperfusion arrhythmia and low blood pressure during PCI, the resolution of elevated ST-segment and the changes of left ventricular end-diastolic diameter(LVEDD) and left ventricular ejection fraction (LVEF) were observed. Results In L-CN treated group, the peak value of CK-MB was significantly lower and the time to peak value of CK-MB was shorter compared with the control group. The incidence of reperfusion arrhythmia and low blood pressure during PCI was markedly reduced and the incidence of 50% resolution of elevated ST-segment in 1h after PCI was increased in the L-CN treated group. LVEDD was less but LVEF was higher in the treatment group compared with the control group 3 months after PCI. Conclusion L-CN has significant myocardial protection effects in patients with AMI undergoing primary PCI, which is characterized by inhibition of the reperfusion injury , reduction of infarction area and improvement of left ventricular remodeling.
What problem does this paper attempt to address?